The U.S. pharmaceutical market is expected to grow at a CAGR of 5.5% from 2024 to 2030. With the rising prevalence and awareness of chronic conditions and infectious diseases among the population, demand for customized medicines, personalized drugs, vaccines, and therapies is also increasing.
Furthermore, growing per capita healthcare expenditure in developed and emerging countries and the increase in the patient pool has driven the demand for medicines to treat these diseases and has significantly impacted market growth.
